Cite
HARVARD Citation
Otsubo, T. et al. (n.d.). P-108 Infliximab-Associated Suppression of Cytokine Release by Mucosal Explants Predicts Success of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases. p. . [Online].